Home › Asset managers › Compare 2025-2026 › Fidelity vs American Century
Fidelity 2025-2026 · American Century 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 83,213 | 76,370 | 3,435 | 3,408 | 95.7% | 94.1% |
| Board proposals | 67,460 | 61,149 | 3,251 | 3,060 | 95.0% | 93.1% |
| E&S shareholder proposals | 174 | 125 | 0 | 49 | 100.0% | 91.9% |
| Other items | 15,579 | 15,096 | 184 | 299 | 98.8% | 98.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
3,251 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Fidelity | American Century |
|---|---|---|---|---|---|---|
| CLP HOLDINGS LTD | May 8, 2026 | ELECT CHAN BERNARD CHARNWUT AS DIRECTOR Director Elections |
Board | For | AGAINST 12 funds |
FOR 2 funds |
| CMB.TECH NV | May 21, 2026 | Approve Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| CMB.TECH NV | May 21, 2026 | Reelect Debemar BV, Permanently Represented by Patrick De Brabandere, as Member of the Supervisory Board Director Elections |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| CNA FINANCIAL CORPORATION | April 29, 2026 | Approval of an amendment to the Amended and Restated CNA Financial Corporation Incentive Compensation Plan to increase by 5,000,000 shares the authorized number of shares of common stock that may be issued with respect to awards under the Incentive Compensation Plan. Compensation |
Board | For | FOR 10 funds |
AGAINST 9 funds |
| CNH INDUSTRIAL N V | May 8, 2026 | Approval of executive compensation ("say-on-pay") (advisory vote) Say-on-Pay |
Board | For | FOR 33 funds |
AGAINST 6 funds |
| COCA-COLA FEMSA SAB DE CV | March 24, 2026 | Elect Board Chair and Secretaries; Approve Remuneration of Directors; Verify Director's Independence Classification Corporate Governance |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| CODA OCTOPUS GROUP, INC. | September 10, 2025 | To vote, on an advisory basis, to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| COFACE SA | May 19, 2026 | Approve Compensation of Xavier Durand, CEO Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 6 funds |
| COGENT BIOSCIENCES, INC. | June 9, 2026 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 62 funds |
AGAINST 6 funds |
| COGENT COMMUNICATIONS HOLDINGS, INC. | May 1, 2026 | To approve the Third Amended and Restated 2017 Incentive Award Plan of the Company, including an increase in the number of shares available for issuance thereunder by 1.5 million shares. Compensation |
Board | For | FOR 17 funds |
AGAINST 2 funds |
| COHERENT CORP. | November 13, 2025 | Non-binding advisory vote to approve compensation paid to named executive officers in fiscal year 2025. Say-on-Pay |
Board | For | FOR 56 funds |
AGAINST 4 funds |
| COHERUS ONCOLOGY, INC. | May 29, 2026 | To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 1 fund |
| COHERUS ONCOLOGY, INC. | May 29, 2026 | To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 2 funds |
| COHU, INC. | May 15, 2026 | Approve the Cohu, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | FOR 13 funds |
AGAINST 6 funds |
| COLLEGIUM PHARMACEUTICAL, INC. | May 14, 2026 | Approval of, on an advisory basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | FOR 18 funds |
AGAINST 10 funds |
| COLLIERS INTERNATIONAL GROUP INC | March 31, 2026 | ELECT DIRECTOR BENJAMIN F. STEIN Director Elections |
Board | For | FOR 14 funds |
WITHHOLD 10 funds |
| COLLIERS INTERNATIONAL GROUP INC | March 31, 2026 | ELECT DIRECTOR P. JANE GAVAN Director Elections |
Board | For | FOR 14 funds |
WITHHOLD 10 funds |
| COLONIAL SFL SOCIMI SA | June 17, 2026 | APPROVE LONG-TERM INCENTIVE PLAN Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| COLONIAL SFL SOCIMI SA | June 17, 2026 | AUTHORIZE ISSUANCE OF CONVERTIBLE BONDS, DEBENTURES, WARRANTS, AND OTHER DEBT SECURITIES WITH EXCLUSION OF PREEMPTIVE RIGHTS UP TO 20 PERCENT OF CAPITAL Capital Structure |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| COLOPLAST A/S | December 4, 2025 | REELECT NIELS PETER LOUIS-HANSEN AS DIRECTOR Director Elections |
Board | For | FOR 2 funds |
ABSTAIN 3 funds |
| COMMERCE.COM, INC. | May 14, 2026 | Non-binding advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 2 funds |
| COMMERCIAL METALS COMPANY | January 14, 2026 | The approval, on an advisory basis, of the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 35 funds |
AGAINST 14 funds |
| COMMSCOPE HOLDING COMPANY, INC. | October 16, 2025 | A proposal to approve, on an advisory, non-binding basis, certain compensation that has, will or may be paid or become payable to the Company's named executive officers in connection with the CCS Sale Transaction (the ''Advisory Compensation Proposal''). Say-on-Pay |
Board | For | FOR 20 funds |
AGAINST 2 funds |
| COMMVAULT SYSTEMS, INC. | August 7, 2025 | To approve additional shares to be available for grant under Commvault's 2016 Omnibus Incentive Plan. Compensation |
Board | For | FOR 32 funds |
AGAINST 6 funds |
| COMPAGNIE DES ALPES SA | March 11, 2026 | Authorize up to 2 Percent of Issued Capital for Use in Restricted Stock Plans Compensation |
Board | For | FOR 1 fund |
AGAINST 6 funds |
| COMPAGNIE FINANCIERE RICHEMONT SA | September 10, 2025 | REAPPOINT BRAM SCHOT AS MEMBER OF THE COMPENSATION COMMITTEE Corporate Governance |
Board | Not determined | AGAINST 14 funds |
FOR 5 funds |
| COMPAGNIE FINANCIERE RICHEMONT SA | September 10, 2025 | REELECT ANTON RUPERT AS DIRECTOR Director Elections |
Board | Not determined | FOR 14 funds |
AGAINST 5 funds |
| COMPAGNIE FINANCIERE RICHEMONT SA | September 10, 2025 | REELECT BRAM SCHOT AS DIRECTOR Director Elections |
Board | Not determined | AGAINST 14 funds |
FOR 5 funds |
| COMPAGNIE FINANCIERE RICHEMONT SA | September 10, 2025 | REELECT GARY SAAGE AS DIRECTOR Director Elections |
Board | Not determined | FOR 14 funds |
AGAINST 5 funds |
| COMPANIA DE SANEAMENTO DE MINAS GERAIS - COPASA MG | April 30, 2026 | Elect Gustavo de Oliveira Barbosa as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 5 funds |
| COMPANIA DE SANEAMENTO DE MINAS GERAIS - COPASA MG | April 30, 2026 | Elect Marilia Carvalho de Melo as Director Director Elections |
Board | For | FOR 2 funds |
AGAINST 5 funds |
| COMPASS THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 18 funds |
AGAINST 3 funds |
| COMPASS THERAPEUTICS, INC. | June 10, 2026 | To elect two class III directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. Thomas J. Schuetz, M.D., Ph.D. Director Elections |
Board | For | FOR 17 funds |
WITHHOLD 2 funds |
| COMPASS, INC. | May 14, 2026 | Advisory Vote to Approve 2025 Named Executive Officer Compensation ("Say-on-Pay Vote") Say-on-Pay |
Board | For | FOR 75 funds |
AGAINST 5 funds |
| CONFLUENT, INC. | February 12, 2026 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Confluent, Inc. to its named executive officers in connection with the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | FOR 22 funds |
AGAINST 3 funds |
| CONMED CORPORATION | May 18, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 5 funds |
| CONSENSUS CLOUD SOLUTIONS, INC. | June 10, 2026 | To approve an amendment and restatement of the Company's 2021 Stock Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 3 funds |
| CONSENSUS CLOUD SOLUTIONS, INC. | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| CONSTELLIUM SE | May 21, 2026 | Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company's named executive officers Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 8 funds |
| CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES SA | June 13, 2026 | Authorize Increase in Capital up to 50 Percent via Issuance of Equity or Equity-Linked Securities, Excluding Preemptive Rights of up to 20 Percent Capital Structure |
Board | For | FOR 3 funds |
AGAINST 10 funds |
| CONSUMER PORTFOLIO SERVICES, INC. | November 19, 2025 | To approve an advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 6 funds |
| CONSUMER PORTFOLIO SERVICES, INC. | November 19, 2025 | To approve the Company's 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| CONTANGO ORE, INC. | March 17, 2026 | The Incentive Plan Proposal - To approve the 2026 Omnibus Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 1 fund |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | Approve 2026 A Share Employee Stock Ownership Plan and Its Summary Compensation |
Board | For | AGAINST 28 funds |
FOR 4 funds |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | Approve Administrative Measures for the 2026 A Share Employee Stock Ownership Plan Compensation |
Board | For | AGAINST 28 funds |
FOR 4 funds |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | Approve Entrusted Wealth Management Plan Extraordinary Transactions |
Board | For | FOR 30 funds |
AGAINST 4 funds |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | Approve Proposed Grant of Full Authority to the Board to Handle All Specific Matters Related to the 2026 A Share Employee Stock Ownership Plan Compensation |
Board | For | AGAINST 28 funds |
FOR 4 funds |
| CONTINENTAL AG | April 30, 2026 | REELECT SABINE NEUSS TO THE SUPERVISORY BOARD Director Elections |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| CONVATEC GROUP PLC | May 21, 2026 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 3 funds |
| CORBION NV | May 13, 2026 | Grant Board Authority to Issue Shares Up to 10 Percent of Issued Capital in Case of Mergers, Acquisitions, or Strategic Alliances Capital Structure |
Board | For | FOR 2 funds |
AGAINST 6 funds |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | May 13, 2026 | Approval of an amendment to the Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Compensation Plan to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares to 5,000,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | May 13, 2026 | Approval, on an advisory basis, of the executive compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 4 funds |
| CORE LABORATORIES INC. | May 12, 2026 | To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 9 funds |
| CORE SCIENTIFIC, INC. | May 12, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 2 funds |
| CORECARD CORPORATION | October 28, 2025 | Proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to CoreCard's named executive officers that is based on or otherwise relates to the Merger (the ''Advisory Compensation Proposal''). Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 6 funds |
| COREWEAVE, INC. | June 8, 2026 | Election of Class I Director: Michael Intrator Director Elections |
Board | For | FOR 19 funds |
WITHHOLD 2 funds |
| CORVEL CORPORATION | August 7, 2025 | To approve the 2025 Stock Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 6 funds |
| COSCO SHIPPING PORTS LTD | May 22, 2026 | Elect Zhu Tao as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| COSMAX INC. | March 26, 2026 | Approve Total Remuneration of Inside Directors and Outside Directors Compensation |
Board | For | FOR 4 funds |
AGAINST 6 funds |
| COSMO PHARMACEUTICALS N.V. | April 10, 2026 | AUTHORIZE BOARD TO EXCLUDE PREEMPTIVE RIGHTS FROM SHARE ISSUANCES UNDER THE AUTHORIZATIONS MENTIONED IN PROPOSAL 13 Capital Structure |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| COSMO PHARMACEUTICALS N.V. | April 10, 2026 | GRANT BOARD AUTHORITY TO ISSUE SHARES UP TO 10 PERCENT OF ISSUED CAPITAL PLUS ADDITIONAL 10 PERCENT IN CASE OF TAKEOVER/MERGER Capital Structure |
Board | For | FOR 2 funds |
AGAINST 5 funds |
| COUSINS PROPERTIES INCORPORATED | April 28, 2026 | Approve the Cousins Properties Incorporated Amended and Restated 2019 Omnibus Incentive Stock Plan. Compensation |
Board | For | FOR 16 funds |
AGAINST 1 fund |
| CPFL ENERGIA SA | April 29, 2026 | Ratify Peng Sun and Zhonghua Wei as Directors Director Elections |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| CPI EUROPE AG | May 5, 2026 | Approve Issuance of Warrants/Bonds with Warrants Attached/Convertible Bonds without Preemptive Rights up to Aggregate Nominal Amount of EUR 716.2 Million; Approve Creation of EUR 13.9 Million Pool of Capital to Guarantee Conversion Rights Capital Structure |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| CRA INTERNATIONAL, INC. | July 17, 2025 | To approve, on an advisory basis, the compensation paid to CRA's named executive officers, as disclosed in the proxy statement for the 2025 meeting of its shareholders. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 7 funds |
| CRANSWICK PLC | July 28, 2025 | Approve Remuneration Committee Report Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| CRAWFORD & COMPANY | May 14, 2026 | Proposal to approve an amendment to the Crawford & Company 2016 Omnibus Stock and Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 3 funds |
| CREDITO EMILIANO SPA CREDEM | April 29, 2026 | Approve Second Section of the Remuneration Report Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 6 funds |
| CREDO TECHNOLOGY GROUP HOLDING LIMITED | October 13, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 33 funds |
AGAINST 8 funds |
| CREEK & RIVER Co., Ltd. | May 27, 2026 | Elect Director Ikawa, Yukihiro Director Elections |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| CRINETICS PHARMACEUTICALS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; Say-on-Pay |
Board | For | FOR 58 funds |
AGAINST 8 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| CROWN CASTLE INC. | May 20, 2026 | The non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 2 funds |
| CRYOPORT, INC. | June 5, 2026 | To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; Compensation |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| CRYOPORT, INC. | June 5, 2026 | To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement; Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 5 funds |
| CRYSTAL INTERNATIONAL GROUP LIMITED | May 29, 2026 | Elect Mak Wing Sum Alvin as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| CSPC PHARMACEUTICAL GROUP LIMITED | May 28, 2026 | Elect Law Cheuk Kin Stephen as Director Director Elections |
Board | For | AGAINST 9 funds |
FOR 4 funds |
| CTBC Financial Holding Co., Ltd. | June 12, 2026 | Approve Issuance of Restricted Stocks Compensation |
Board | For | FOR 17 funds |
AGAINST 5 funds |
| CTP N.V. | May 20, 2026 | GRANT BOARD AUTHORITY TO ISSUE SHARES Capital Structure |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| CULLINAN THERAPEUTICS, INC. | June 16, 2026 | Proposal to vote, on an advisory basis, to approve our named executive officer compensation. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 5 funds |
| CUSHMAN & WAKEFIELD LTD. | May 14, 2026 | Approval of our 2026 Omnibus Share and Cash Incentive Plan. Compensation |
Board | For | FOR 23 funds |
AGAINST 5 funds |
| CVRx, Inc. | June 1, 2026 | Election of Class II Directors: Joseph Slattery Director Elections |
Board | For | FOR 11 funds |
WITHHOLD 1 fund |
| CVRx, Inc. | June 1, 2026 | Election of Class II Directors: Kevin Hykes Director Elections |
Board | For | FOR 11 funds |
WITHHOLD 1 fund |
| CYTEK BIOSCIENCES, INC. | June 10, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 6 funds |
| Cal-Maine Foods, Inc. | October 3, 2025 | Election of Class I Directors: Camille S. Young Director Elections |
Board | For | FOR 26 funds |
WITHHOLD 9 funds |
| Caliway Biopharmaceuticals Co. Ltd. | May 22, 2026 | Amend 2025 Regulations of the Issuance of Restricted Stocks Compensation |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| Caliway Biopharmaceuticals Co. Ltd. | May 22, 2026 | Approve Issuance of Restricted Stocks Compensation |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| Canaccord Genuity Group Inc. | August 8, 2025 | Advisory Vote on Executive Compensation Approach Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Canon Marketing Japan, Inc. | March 26, 2026 | Appoint Statutory Auditor Arai, Eiichi Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| Canon Marketing Japan, Inc. | March 26, 2026 | Elect Director Adachi, Masachika Director Elections |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| Cardinal Energy Ltd. | May 7, 2026 | Elect Director John A. Brussa Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 8 funds |
| Cardinal Energy Ltd. | May 7, 2026 | Elect Director M. Scott Ratushny Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 8 funds |
| CareCloud, Inc. | June 4, 2026 | Election of Directors: Cameron Munter Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 4 funds |
| Carter's, Inc. | May 13, 2026 | Election of nine nominated directors: Stephanie P. Stahl Director Elections |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| Cementir Holding NV | April 23, 2026 | Approve Remuneration Report Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| Cementir Holding NV | April 23, 2026 | Reelect Alessandro Caltagirone as Non-Executive Director Director Elections |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| Cementir Holding NV | April 23, 2026 | Reelect Fabio Corsico as Non-Executive Director Director Elections |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| Center Laboratories, Inc. | June 12, 2026 | Approve Issuance of Shares via a Private Placement Capital Structure |
Board | For | FOR 1 fund |
AGAINST 4 funds |
← Previous Page 7 of 33 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.